Valneva SE (EPA:VLA)
France · Delayed Price · Currency is EUR 4.396
+0.140 (3.29%)
Jan 12, 2026, 11:43 AM CET
Valneva SE Market Cap
Valneva SE has a market cap or net worth of €735.26 million as of January 12, 2026. Its market cap has increased by 109.42% in one year.
Market Cap
735.26M
Enterprise Value
787.65M
Revenue
179.91M
Ranking
n/a
PE Ratio
n/a
Stock Price
€4.40
Market Cap Chart
Since June 29, 2007, Valneva SE's market cap has increased from 99.08M to 735.26M, an increase of 642.10%. That is a compound annual growth rate of 11.41%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 9, 2026 | 735.26M | 14.47% |
| Dec 31, 2025 | 642.32M | 82.94% |
| Dec 31, 2024 | 351.10M | -46.40% |
| Dec 29, 2023 | 655.08M | -23.93% |
| Dec 30, 2022 | 861.12M | -66.55% |
| Dec 31, 2021 | 2.57B | 265.20% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| EssilorLuxottica Société anonyme | 128.15B |
| Sanofi | 102.75B |
| Sartorius Stedim Biotech | 20.85B |
| bioMérieux | 13.33B |
| Eurofins Scientific SE | 12.24B |
| Ipsen | 10.46B |
| ABIVAX Société Anonyme | 7.71B |
| Virbac | 3.05B |